Skip to main content

Table 2 Overall survival with clinicopathological findings

From: Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy

Variables n = 79 (%) 3-years OS rate (%) 5-year OS rate (%) Pvalue*  
Age (years)      
<60 27 (34.2) 70.4 63.0 0.11  
≥60 52 (65.8) 52.5 43.1   
Gender      
Male 68 (86.1) 58.9 50.8 0.91  
Female 11 (13.9) 57.7 46.2   
Location      
Upper 12 (15.2) 50.0 41.7 control  
Middle 47 (59.5) 61.0 48.2 0.76  
Lower 20 (25.3) 60.0 60.0 0.38  
cT      
cT1 24 (30.4) 85.9 76.4 control  
cT2 8 (10.1) 85.7 71.4 0.94  
cT3 47 (59.5) 41.5 34.4 0.0006  
cN      
cN0 29 (36.7) 80.8 72.7 0.0028  
cN1-3 50 (63.3) 47.0 38.2   
cStage      
cStageI 22 (27.8) 89.5 79.0 control  
cStageII 17 (21.5) 67.0 60.3 0.25  
cStageIII 40 (50.6) 40.0 31.8 0.0002  
Clinical course      
CR continue 35 (44.3) 87.5 84.1 <0.0001  
Failure 44 (55.7) 37.3 25.5   
  1. *log-rank test.
  2. OS, overall survival.